Zevra Therapeutics Inc (ZVRA) (Q3 2026) Earnings Call Highlights: Revenue Jumps 45% as MIPLYFFA ...
Zevra Therapeutics Inc (ZVRA) posted $37.8 million in Q3 2026 revenue, swung to $19.2 million net income, and outlined plans for an infant label expansion and a Q4 European decision on arimoclomol. Related Stocks: ZVRA ,